- Todos > Medicine Access and Rational Use > Financing
- Todos > Medicine Access and Rational Use > Pricing
(2005; 7 pages)
Policy makers in many countries are struggling to cope with increasing costs for pharmaceuticals.
Pharmaceutical expenses are usually the second or third biggest position in overall healthcare costs after human resource related expenses. Their share of total health care costs can go up to around 50% in developing countries, compared with an average of 14% in OECD countries. This paper looks at the main cost drivers for medicines and discusses options to control costs, trying to provide some guidance for developing a financially sustainable pharmaceutical policy framework...